Alkem Laboratories is currently trading at Rs. 1819.00, up by 2.15 points or 0.12% from its previous closing of Rs. 1816.85 on the BSE.
The scrip opened at Rs. 1820.25 and has touched a high and low of Rs. 1827.15 and Rs. 1812.00 respectively. So far 223 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2265.00 on 10-Sep-2018 and a 52 week low of Rs. 1660.35 on 28-Jun-2019.
Last one week high and low of the scrip stood at Rs. 1840.00 and Rs. 1711.55 respectively. The current market cap of the company is Rs. 21787.73 crore.
The promoters holding in the company stood at 66.03%, while Institutions and Non-Institutions held 8.69% and 25.28% respectively.
The US Food and Drug Administration (USFDA) has completed inspection at Alkem Laboratories’ manufacturing facility located at Daman. The agency had conducted inspection from August 26, 2019 to August 30, 2019. At the end of the inspection, the company has received a Form 483 with two observations.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.